Vertex 2026년 3월 10일 Vertex to seek approval of IgAN drug after Phase III success - Clinical Trials Arena
Vertex 2026년 3월 10일 Vertex races to FDA after phase 3 kidney disease data impress analysts - Fierce Biotech
Vertex 2026년 1월 20일 Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th - Vertex Pharmaceuticals Newsroom
BioPharma Dive 2026년 1월 12일 AbbVie buys into PD-1/VEGF sweepstakes; Alnylam and Vertex set expectations